(2-ナフタレニルオキシ)アセトアミド物理性質 沸点443.7±28.0 °C(Predicted) 比重(密度)1.220±0.06 g/cm3(Predicted) 酸解離定数(Pka)15.33±0.40(Predicted) 安全性情報 HSコード2924297099 危険有害性情報のコード(GHS) (2-ナフタレニルオキシ)アセトアミド 価格 ...
比重(密度)1.143±0.06 g/cm3(Predicted) 酸解離定数(Pka)8.27±0.20(Predicted) 危険有害性情報のコード(GHS) ビス(2-ナフタレニルメチル)アミン 価格 ビス(2-ナフタレニルメチル)アミン 化学特性,用途語,生産方法 ビス(2-ナフタレニルメチル)アミン 生産企業...
2.7 pKa 5.36±0.10(Predicted) 2.8 Water Solubility pyridine: soluble50mg/mL 2.9 Stability Stable. Combustible. Incompatible with strong oxidizingagents. 2.10 StorageTemp Keep in dark place,Inert atmosphere,2-8°C3. Use and Manufacturing3.1 Description 2,3-DIAMINONAPHTHALENE, with the chemical formula...
2.1 pKa 5.34±0.10(Predicted) 2.2 StorageTemp Keep in dark place,Inert atmosphere,Room temperature3. MSDS2.Hazard identification 2.1 Classification of the substance or mixture no data available 2.2 GHS label elements, including precautionary statements Pictogram(s) no data available Signal word ...
Najděte obrázky na téma Řepka. ✓ Bez licenčních poplatků ✓ Není nutné uvádět zdroj ✓ Vysoce kvalitní obrázky.
酸性度係数(pKa): pKa 2.5(H2O) (Uncertain) ひせんこうど: +63.7° (c=1, 0.2M pH7 phosphate buffer) 密度みつど: 1.76 セキュリティ情報 RTECS番号:XI0329000 WGKドイツ:3 セキュリティの説明:S22; S24; S37; S45 リスク用語:R42/43 ...
Dedicated peripherals reinforce security: a fast AES coprocessor, a secure AES coprocessor with DPA resistance and hardware unique key that can be shared by hardware with fast AES, a PKA (public key accelerator) with DPA resistance, a HASH hardware accelerator, and a true random number generator...
The devices embed several peripherals reinforcing security: a fast AES coprocessor, a secure AES coprocessor with DPA resistance and hardware unique key that can be shared by hardware with fast AES, a PKA (public key accelerator) with DPA resistance, an on-the-fly decryption engine for Octo-SPI...
• Digital Signature Generate (CSNDDSG),Digital Signature Verify (CSNDDSV),および PKA Key Token Build (CSNDPKB) 呼び出し可能サービスは,RSA-PSS Signatures のサポー トを追加し,より高度な確実性と強力なシグニチャー・サポートを提供します. • PKA Key Generate (CSNDPKG) および PKA...
WO2006136829A2 2006-12-28 PYRAZOLE DERIVATIVES AND THEIR USE AS PKA AND PKB MODULATORS WO2007021982A2 2007-02-22 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR WO2007028654A1 2007-03-15 PYRIDINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF PSYCHOTIC DISORDERS WO2007039420A1 2007-04...